Human Recombinant FGF4 (PHG0154)
From ToxBankWiki
Human Recombinant FGF4 (PHG0154)
Human Recombinant FGF4 (PHG0154)
Molecular Description
Molecular Weight | 19.7 kDa |
Glycosylation |
Biological Source
Name | E. coli |
Recombinant or animal source | Recombinant |
Characterisation Data
PAGE with antibodies | |
Cell culture testing e.g. growth promotion, cytokine expression |
Quality Control Parameters
Biological assay/activity | ED50 ≤ 0.5 ng/mL (≥ 2 × 106 units/mg), determined by the dose dependent stimulation of thymidine uptake byBaF3 cells expressing FGF–receptors. FGF–4 is a heparin binding growth factor expressed by tumor cells andembryonic cells which has mitogenic activity with fibroblasts and endothelial cells. |
Company | Product Link |
---|---|
Life Technologies | PHG0154 |
Publications | |
SEURAT Protocols | Search for Protocols in the ToxBank Data Warehouse |
SEURAT Data | Search for Data in the ToxBank Data Warehouse |
Other Links |